Multi-center Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension

Completed · Phase 2 · Has a placebo group

Conditions studied: Open-angle Glaucoma or Ocular Hypertension

In brief

The purpose of this study is to investigate the safety and efficacy of four concentrations of DE-117 ophthalmic solution.

Key facts

Study ID

NCT01868126

Run by

Santen Inc.

People needed

91

Starts

2013-05-01

Expected to finish

2013-09-01

Last updated by the study team

2018-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Newport Beach, California, United States
• Study site — Morrow, Georgia, United States
• Study site — Kansas City, Missouri, United States
• Study site — Rochester, New York, United States
• Study site — Cleveland, Ohio, United States
• Study site — Austin, Texas, United States
• Study site — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.